C4 Therapeutics, Inc. (CCCC) Form 10-K Annual Reports
C4 Therapeutics, Inc. (CCCC) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CCCC
CIK: 1662579
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerSuzanne St. George
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001470831-26-000925 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001470831-26-000924 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | 8-K | 0001628280-26-063497 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-18 | FORM 4 | 0001470831-26-000895 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008193 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008190 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000920 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003524 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0002050709-26-000022 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008065 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008039 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000895421-26-000231 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001628280-26-055494 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001628280-26-055490 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002217 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-10 | FORM 4 | 0001470831-26-000705 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001470831-26-000688 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001470831-26-000689 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000673 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000670 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000667 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000665 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000663 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000661 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-24 | FORM 4 | 0001470831-26-000659 | View SEC Doc Filr Page |